Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × enfortumab vedotin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Transitional Cell 21 Urinary Bladder Neoplasms 16 Ureteral Neoplasms 7 Urethral Neoplasms 3 Urologic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Muscle Invasive Bladder Urothelial Carcinoma 2 Metastatic Urothelial Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Bladder Cancer 2 Urothelial Cancer 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Peripheral Nervous System Diseases 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Muscle-invasive Bladder Cancer 1 Metastatic Urothelial Cancer and Other Malignant Solid Tumors 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Paclitaxel 80 Carboplatin 65 pembrolizumab 62 Cisplatin 25 Bevacizumab 25 Letrozole 21 Doxorubicin 20 Radiotherapy 19 olaparib 16 lenvatinib 16 Taxes 16 Megestrol Acetate 16 Docetaxel 15 dostarlimab 14 Specimen Handling 14 Nivolumab 14 Metformin 13 Magnetic Resonance Spectroscopy 12 durvalumab 11 Fulvestrant 11 temsirolimus 10 Medroxyprogesterone Acetate 10 Indocyanine Green 10 abemaciclib 9 Trastuzumab 9 Radiation 9 Gemcitabine 9 Brachytherapy 9 Biopsy 9 Observation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07139977 2026-01-20

EV-4-EC

Medical College of Wisconsin

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡